User profiles for "author:Jose G Mantilla"

Jose G. Mantilla

NYU Grossman School of Medicine
Verified email at nyulangone.org
Cited by 552

Extranodal Rosai-Dorfman disease: clinicopathologic series of 10 patients with radiologic correlation and review of the literature

JG Mantilla, S Goldberg-Stein… - American journal of …, 2016 - academic.oup.com
Objectives: To describe the radiologic and clinicopathologic features of extranodal Rosai-
Dorfman disease (RDD) in our patient population. Methods: Via a data mining engine, we …

A novel MBTD1‐PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review

L Han, YJ Liu, RW Ricciotti… - Genes, Chromosomes …, 2020 - Wiley Online Library
The classification of endometrial stromal sarcoma (ESS) has been refined and aided by the
discovery of various recurrent gene translocations. Low‐grade ESS (LG‐ESS) is most …

GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics

JG Mantilla, T Antic, M Tretiakova - Human pathology, 2017 - Elsevier
Clear cell papillary renal cell carcinoma (CCPRCC) is a low-grade, indolent neoplasm with
no reported cases of death from disease or metastasis. These lesions can show clinical …

Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells

PH Goff, L Riolobos, BJ LaFleur, MB Spraker… - Clinical Cancer …, 2022 - AACR
Purpose: To characterize changes in the soft-tissue sarcoma (STS) tumor immune
microenvironment induced by standard neoadjuvant therapy with the goal of informing …

Detecting disease‐defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next‐generation sequencing—Molecular …

JG Mantilla, RW Ricciotti, E Chen… - Genes …, 2019 - Wiley Online Library
Detection of disease‐defining gene fusions in sarcoma has led to refining their classification,
as well as to discover several new entities. The advent of anchored multiplex PCR/targeted …

[HTML][HTML] CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes

BA Schroeder, NA LaFranzo, BJ LaFleur… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Dedifferentiated liposarcoma (DDLPS) is one of the most common soft tissue
sarcoma subtypes and is devastating in the advanced/metastatic stage. Despite the …

[HTML][HTML] Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a …

YJ Liu, W Wang, J Yeh, Y Wu, JG Mantilla… - Modern Pathology, 2021 - Elsevier
Translocations involving FN1 have been described in a variety of neoplasms that share the
presence of a cartilage matrix and may also contain a variable extent of calcification …

Is chemotherapy associated with improved overall survival in patients with dedifferentiated chondrosarcoma? A SEER database analysis

LD Cranmer, B Chau, JG Mantilla… - Clinical Orthopaedics …, 2022 - journals.lww.com
Background Dedifferentiated chondrosarcoma is a chondrosarcoma subtype associated
with high rates of recurrence and a poor prognosis. Others have proposed treatment of …

[HTML][HTML] Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation …

JG Mantilla, RW Ricciotti, EY Chen, YJ Liu, BL Hoch - Modern Pathology, 2019 - Elsevier
Dedifferentiated liposarcoma is defined as progression of atypical lipomatous tumor/well-
differentiated liposarcoma to a higher grade usually non-lipogenic sarcoma, with …

Payload fuel energy efficiency as a metric for aviation environmental performance

J Hileman, JB Katz, JG Mantilla, G Fleming - 2008 - rosap.ntl.bts.gov
Aviation provides productivity in the form of transporting passengers and cargo long
distances in a shorter period of time than is available via land or sea. Given the recent rise in …